Tagclinical trials

Child Living with HIV Maintains Remission Without Drugs Since 2008

C

National Institute of Allergy and Infectious Diseases (NIAID), July 24, 2017 A nine-year-old South African child who was diagnosed with HIV infection at one month of age and received anti-HIV treatment during infancy has suppressed the virus without anti-HIV drugs for eight and a half years, scientists reported today at the 9th IAS Conference on HIV Science in Paris. This case appears to be the...

New kind of male contraceptive faces biggest hurdle: drugmakers

N

The Age,  Published APRIL 2 2017 Doctors are on the cusp of launching the first new male contraceptive in more than a century. But rather than a Big Pharma lab, the breakthrough is emerging from a university start-up in the heart of rural India. Years of human trials on the injectable, sperm-zapping product are coming to an end, and researchers are preparing to submit it for regulatory approval...

Upcoming free community forum: PrEP_SA_NOW!

U

SAMESH,  April 2017 There has been a lot of community interest in the PrEPX-SA trial. You are invited to an upcoming community forum where a distinguished panel of experts and community members involved in the field will discuss PrEP, a powerful new tool to prevent HIV and the upcoming PrEPX-SA study. The panel will include: Associate Professor Edwina Wright (Alfred Health) Professor Steve...

Consumer feedback sought on proposed patient access pathway for medical cannabis in SA

C

Health Consumers Alliance of South Australia, 2017 The Department for Health and Ageing is seeking feedback on a proposed patient access pathway for medical cannabis in South Australia. A discussion paper has been released which proposes a patient access pathway including amendments to South Australian controlled substances legislation, to ensure national consistency towards safe and appropriate...

VAC announces $100,000 for PREPX trial [for HIV prevention]

V

Gay News Network, Wednesday 18 January 2017 The Victorian AIDS Council has announced it will give an additional $100,000 to the PrEPX trial to fund access to pre-exposure prophylaxis for HIV (PrEP) for 600 Victorians at risk. VAC’s announcement comes months after PrEPX reached capacity for men living in metropolitan Melbourne. The VAC said there is already a substantial waiting list for those...

Welcome to SASHA

SASHA is a current awareness service with news and views on various aspects of sexual health and sexuality, from a wide range of sources. These range from credible sources of sexual health and related information, to relevant opinion pieces in the media.

Categories